Literature DB >> 20567585

Advances in hepatology: current developments in the treatment of hepatitis and hepatobiliary disease.

.   

Abstract

Entities:  

Year:  2010        PMID： 20567585      PMCID： PMC2886491     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Telaprevir for previously treated chronic HCV infection.

Authors:  John G McHutchison; Michael P Manns; Andrew J Muir; Norah A Terrault; Ira M Jacobson; Nezam H Afdhal; E Jenny Heathcote; Stefan Zeuzem; Hendrik W Reesink; Jyotsna Garg; Mohammad Bsharat; Shelley George; Robert S Kauffman; Nathalie Adda; Adrian M Di Bisceglie
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

Review 2.  The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus.

Authors:  Ivan Gentile; Maria Aurora Carleo; Federico Borgia; Giuseppe Castaldo; Guglielmo Borgia
Journal:  Expert Opin Investig Drugs       Date:  2010-01       Impact factor: 6.206

3.  Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

Authors:  John G McHutchison; Gregory T Everson; Stuart C Gordon; Ira M Jacobson; Mark Sulkowski; Robert Kauffman; Lindsay McNair; John Alam; Andrew J Muir
Journal:  N Engl J Med       Date:  2009-04-30       Impact factor: 91.245

4.  Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients.

Authors:  Eric Lawitz; Maribel Rodriguez-Torres; Andrew J Muir; Tara L Kieffer; Lindsay McNair; Ariya Khunvichai; John G McHutchison
Journal:  J Hepatol       Date:  2008-04-29       Impact factor: 25.083
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.